news Motif Bio announces intention to float on AIM 3 February 2015 | By Motif Bio Motif Bio plc is seeking to raise at least £4 million through a placing of new ordinary shares and admission to trading on AIM...
news Actavis completes acquisition of Furiex Pharmaceuticals 3 July 2014 | By Actavis Actavis plc announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex Pharmaceuticals, Inc...